In this issue:
Therapeutic apheresis for liposomal doxorubicin
Survival benefit with SLN biopsy
Routine CT/MRIs in HER-2-positive breast cancer?
Early tamoxifen discontinuation
Gynaecological tolerability advantage of anastrozole
Neoadjuvant endocrine therapy in receptor-positive tumours
Anthracycline substitution with Caelyx/Doxil
Early conception following breast cancer
Optimise hormonal manipulations in the young
Cardiac safety guidelines for trastuzumab
Download PDF